Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Nextleaf Solutions Ltd. is a Canada-based company, which is a federally regulated manufacturer and distributor of cannabis vapes and oils under its brand, Glacial Gold. The Company is a cannabis extractor and processor, with a focus on developing intellectual property for the extraction, distillation formulation, and delivery of cannabinoids. It commercializes its intellectual property portfolio through IP licensing, production of cannabidiol (CBD) and tetrahydrocannabinol (THC) oils, through its subsidiary, Nextleaf Labs Ltd. (Labs), and selling products through provincial distribution boards for the adult-use market under the brand Glacial Gold. It sells its branded products to government distributors and authorized retailers in four provinces in Canada. Its patented ingredient processing technology transforms unsold cannabis and hemp biomass into distillate at an industrial scale. Its other subsidiary is Nextleaf Innovations Ltd., which operates as an extraction solutions company.


CSE:OILS - Post by User

Comment by Rm90090on Dec 24, 2020 6:26pm
126 Views
Post# 32181901

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Patents have value

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Patents have value

Yes and I think that's the point that Canopy will be trying to make - that these procedural patents already exist in Pharma and it is no different.

The argument on the other side (GW) may be that a) these procedures were widely used (albeit In mostly illegal operations) far before it was patented, and b) that the slight changes in procedures that GW has implemented compared to Canopy make it a completely different procedure.

As a NL investor, I am really hoping for a Canopy judgement here. Not only will it make NL's patents stronger, but it will shine a big light on the importance of IP in the cannabis industry. And validate NL's business strategy since 2017.

I wonder how long it will take to get a result in this case.

<< Previous
Bullboard Posts
Next >>